- Home
- WSHP vs INMB Comparison
WSHP vs INMB Comparison
Compare WSHP & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WSHP | INMB |
|---|---|---|
| Founded | 2021 | 2015 |
| Country | Jersey | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 56.7M | 64.7M |
| IPO Year | 2024 | 2018 |
Fundamental Metrics
Financial Performance| Metric | WSHP | INMB |
|---|---|---|
| Price | $2.21 | $1.48 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | 83.7K | ★ 262.9K |
| Earning Date | 11-24-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 11.85 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $50,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 257.14 |
| 52 Week Low | $2.34 | $1.09 |
| 52 Week High | $250.00 | $2.60 |
Technical Indicators
Market Signals| Indicator | WSHP | INMB |
|---|---|---|
| Relative Strength Index (RSI) | 23.07 | 35.63 |
| Support Level | N/A | $1.34 |
| Resistance Level | $7.54 | $1.52 |
| Average True Range (ATR) | 0.34 | 0.12 |
| MACD | -0.08 | 0.01 |
| Stochastic Oscillator | 1.90 | 15.53 |
Price Performance
Historical ComparisonAbout WSHP WeShop Holdings Limited Class A Ordinary Shares
WeShop Holdings Ltd is a community owned social commerce platform offering shoppers shares in the company every time customers make a purchase, recommend a product or refer a new member. WeShop earns revenues from advertising on their platform and commissions on the sales through the platform.
About INMB INmune Bio Inc.
INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. The company's pipeline products include INKmune, XPro1595, and others. It has three product platforms; The CORDStrom product platform, The DN-TNF product platform, and The Natural Killer Cell Priming Platform.